Charles Nix on Why Pharmaceutical Typography Is a Customer-Care Issue

Charles Nix, the senior executive creative director at Monotype, spearheaded a typography redesign for Kenvue, which oversees approximately 140 brands, such as Benadryl, Johnson's, Neutrogena, and Tylenol. The initiative commenced with an audit that highlighted Kenvue's confusion regarding the number of typefaces in use. The team eliminated 14 fonts from a single Aveeno Baby package and standardized typographic elements throughout the brand portfolio. Nix stressed the importance of legibility, particularly with Helvetica, where similar shapes can mislead consumers. He referenced a Monotype study indicating that readability diminishes in small text for individuals over 50. Nix considers typography crucial for both usability and brand identity, comparing it to a blend of art and science. This interview appeared in Design Observer.